State regulation of the pharmaceutical market in the countries of the European Union

Krichevskaya Maya Feliksovna

This article discusses the characteristics of pharmaceutical market regulation in the member states of the European Union. The author considers the correlation of EU regulation with national standards and reveals the characteristic features of regulation in Germany and France. The author focuses on the authorization procedure to place medicinal products for human use on the market of Member States, regulation of price of medicinal products and parallel importation issues. The article concludes that the EU pharmaceutical market is regulated at the EU and national levels. Despite the harmonization and unification of legislation in the EU member states, there is difference in legal regulation, which hinders the development of the common market.

Keywords:EU pharmaceutical market, Unified procedure for the admission of medicines to the EU common market, pricing regulation in Germany and France, Parallel import.